Dapagliflozin + Metformin + Vildagliptin is a fixed-dose combination medication containing Dapagliflozin, Metformin, and Vildagliptin, used for the management of type 2 diabetes mellitus in adults. It works through complementary mechanisms to improve blood sugar control by enhancing insulin effectiveness, reducing glucose production in the liver, increasing insulin release after meals, and promoting the elimination of excess glucose through urine. Dapagliflozin + Metformin + Vildagliptin is usually prescribed along with a healthy diet and regular exercise to support better blood sugar control and reduce the risk of diabetes-related complications.

Dapagliflozin + Metformin + Vildagliptin is a triple-combination medicine designed to provide effective blood sugar control in adults with type 2 diabetes. By combining three different actions, it addresses multiple pathophysiological mechanisms involved in elevated blood glucose levels.

Metformin works by reducing the amount of sugar produced by the liver and helps the body use insulin more effectively. Vildagliptin increases certain hormones in the body that improve insulin release when blood sugar is high and lower glucagon after meals. Dapagliflozin helps the kidneys remove extra sugar from the body through urine, lowering blood sugar independently of insulin.

This combination helps manage both fasting and post-meal blood sugar levels. It is usually considered for patients whose sugar levels are not well controlled with a single medicine or two-drug therapy, or for those who are already taking these medicines separately.

Dapagliflozin + Metformin + Vildagliptin should always be taken alongside a balanced diet, regular exercise, and routine blood sugar monitoring. Your doctor will decide the right dose based on your health, kidney function, and treatment response.

When taken under proper medical guidance, Dapagliflozin + Metformin + Vildagliptin offers a convenient, effective way to manage type 2 diabetes and reduce the risk of long-term complications.

Dapagliflozin + Metformin + Vildagliptin is indicated for the management of type 2 diabetes mellitus in adults. It is especially useful for patients who require a combination therapy approach to achieve optimal blood sugar control.

Type 2 Diabetes Mellitus

Helps manage high blood sugar in adults with type 2 diabetes.

Inadequate Control with Monotherapy or Dual Therapy

Prescribed when diet, exercise, and single or dual oral antidiabetic medications are insufficient to maintain target blood glucose levels.

Control of Fasting and Postprandial Blood Sugar

Addresses both fasting (basal) and after-meal (postprandial) blood glucose through complementary mechanisms.

Reduction of Long-Term Diabetes Complications

By improving glycemic control, it may lower the risk of complications such as heart attack, stroke, kidney damage, and nerve problems (neuropathy).

Triple-Action Glycemic Control

Targets the liver, pancreas, and kidneys simultaneously for effective fasting and post-meal blood sugar management.

Improved Insulin Efficiency

Enhances glucose utilization and supports insulin secretion in response to meals.

Reduction in Hepatic Glucose Production

Helps lower fasting blood sugar levels through Metformin’s action on the liver.

Enhanced Post-Meal Sugar Regulation

Vildagliptin reduces postprandial glucose spikes by modulating incretin hormones and glucagon.

Urinary Glucose Excretion

Dapagliflozin promotes the removal of excess glucose through urine, independent of insulin.

Weight Management Support

May support modest weight reduction via glucose excretion.

Cardiovascular and Renal Benefits

Dapagliflozin may provide additional protective effects for the heart and kidneys in appropriate patients.

Convenient Combination Therapy

Combines three medications in a single formulation, simplifying treatment and improving adherence.

Like all medications, Dapagliflozin + Metformin + Vildagliptin may cause side effects, though not everyone experiences them.

Common Side Effects

• Nausea, vomiting, or diarrhea (especially at the start of treatment)

• Metallic taste in the mouth

• Genital fungal (yeast) infections

• Increased frequency of urination

• Headache or dizziness

• Upper respiratory tract infection

Uncommon Side Effects

• Constipation

• Joint pain (arthralgia)

• Back pain

• Skin rash or itching

Serious Side Effects (Seek Immediate Medical Attention)

• Lactic Acidosis: Muscle cramps, severe stomach pain, rapid breathing, and extreme tiredness.

• Diabetic Ketoacidosis (DKA): Confusion, fruity-smelling breath, and nausea, even if blood sugar is normal.

• Pancreatitis: Severe and persistent abdominal pain radiating to the back.

• Fournier’s Gangrene: Pain, redness, or swelling in the genital or perianal area.

• Severe Dehydration: Very dry mouth, extreme thirst, and dark urine.

Dapagliflozin + Metformin + Vildagliptin should be taken exactly as prescribed by your doctor. It is usually taken once or twice daily, depending on the specific formulation and your treatment plan.

Swallow the tablet whole with water, and do not crush, chew, or break it, especially if it is a sustained-release (SR) formulation. It is important to take the medication at the same time every day to maintain a steady level in your system.

Regular medical follow-up is recommended to monitor your blood sugar, kidney function, and overall response to treatment while taking Dapagliflozin + Metformin + Vildagliptin.

Dapagliflozin + Metformin + Vildagliptin is a triple-combination therapy that helps manage type 2 diabetes through three complementary mechanisms:

• Renal Glucose Excretion (Dapagliflozin): Inhibits the Sodium-Glucose Co-Transporter 2 (SGLT2) in the kidneys, reducing glucose reabsorption and promoting its elimination through urine.

• Hepatic and Peripheral Glucose Regulation (Metformin): Suppresses glucose production by the liver (hepatic gluconeogenesis), slows intestinal absorption of sugar, and increases muscle sensitivity to insulin for improved glucose uptake.

• Incretin Enhancement (Vildagliptin): Blocks the Dipeptidyl Peptidase-4 (DPP-4) enzyme, increasing incretin hormone levels. This enhances glucose-dependent insulin release from the pancreas and decreases glucagon secretion by the liver.

By acting on multiple pathways, Dapagliflozin + Metformin + Vildagliptin controls both fasting and postprandial blood sugar levels, supports long-term glycemic management, and helps reduce the risk of diabetes-related complications.

• Personal Hygiene: Maintain strict genital hygiene to prevent yeast infections due to increased sugar in the urine.

• Stay Hydrated: Drink at least 8 glasses of water daily to support kidney function and prevent dehydration.

• Check Your Feet: Diabetes can cause nerve damage; inspect your feet daily for any sores, redness, or infections.

• Slow Transitions: To avoid dizziness, get up slowly from a sitting or lying position.

• Alcohol (Moderate): Increases the risk of Lactic Acidosis and unpredictable blood sugar swings.

• Caffeine (Mild): High intake may affect blood glucose control and hydration in some individuals.

• Diuretics (Moderate): May increase the risk of dehydration and low blood pressure when combined with Dapagliflozin.

• NSAIDs (Moderate): Drugs like Ibuprofen can increase the risk of kidney strain and Metformin accumulation.

• Iodinated Contrast (Severe): Medication must be stopped 48 hours before imaging tests to prevent acute kidney issues.

• Insulin/Sulfonylureas (Moderate): May require a dose reduction of these agents to prevent hypoglycemia.

• Renal Impairment (Severe): Increased risk of Metformin-related toxicity and Lactic Acidosis; contraindicated in severe renal failure.

• Heart Failure (Moderate): Requires close monitoring of fluid status, especially when starting Dapagliflozin.

• Severe Infections (Moderate): May increase the risk of ketoacidosis or lactic acidosis during acute illness.

If you miss a dose, take it as soon as you remember with food. If it is almost time for your next dose, skip the missed one and continue your regular schedule. Do not take two doses at once to make up for a missed one.